Murali Guthikonda, MD
Gary Rajah, MD
Neil Klinger, MD
Karmanos Cancer Institute – Detroit Medical Centre, Detroit Michigan
© Synaptive Medical 2019. All rights reserved. For illustrative purposes only and subject to change without notice.
These products may not be approved for medical device use in your jurisdiction. Please contact Synaptive Medical for information on regulatory clearance status in your jurisdiction.
Synaptive, the Synaptive logo, Modus Plan, Modus V, and BrightMatter are trademarks of Synaptive Medical Inc. or its subsidiaries and are protected by law in Canada, the United States, and internationally. All other product and company names mentioned may be trademarks or trade names of their respective owners. Patents pending.
Klinger et al.
*/Murali Guthikonda, MD
Gary Rajah, MD
Neil Klinger, MD
Karmanos Cancer Institute – Detroit Medical Centre, Detroit Michigan
© Synaptive Medical 2019. All rights reserved. For illustrative purposes only and subject to change without notice.
These products may not be approved for medical device use in your jurisdiction. Please contact Synaptive Medical for information on regulatory clearance status in your jurisdiction.
Synaptive, the Synaptive logo, Modus Plan, Modus V, and BrightMatter are trademarks of Synaptive Medical Inc. or its subsidiaries and are protected by law in Canada, the United States, and internationally. All other product and company names mentioned may be trademarks or trade names of their respective owners. Patents pending.